Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Gland Pharma Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]5616.505641.733591.864384.153423.64
Other Operating Revenues0.0022.9932.7416.5639.24
Total Operating Revenues5616.505664.723624.604400.713462.88
      
Other Income213.61170.24240.46223.94134.78
Total Revenue5830.115834.963865.064624.653597.65
      
EXPENSES     
Cost Of Materials Consumed1972.482252.131716.752046.861749.16
Purchase Of Stock-In Trade14.4923.0715.5925.6716.20
Operating And Direct Expenses0.000.00124.8495.0574.59
Changes In Inventories Of FG,WIP And Stock-In Trade103.41127.89-46.9236.69-273.49
Employee Benefit Expenses1401.561256.89403.26338.57311.36
Finance Costs42.0026.207.455.243.41
Depreciation And Amortisation Expenses377.87344.57146.74110.3098.78
Other Expenses855.64671.68386.31347.72282.83
Total Expenses4767.454702.422754.023006.092262.84
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1062.661132.541111.041618.551334.81
      
Exceptional Items0.000.00-56.460.000.00
Profit/Loss Before Tax1062.661132.541054.581618.551334.81
      
Tax Expenses-Continued Operations     
Current Tax364.13349.30277.16395.88339.45
Deferred Tax0.0014.33-2.8014.010.12
Tax For Earlier Years0.00-3.55-0.82-3.00-1.72
Total Tax Expenses364.13360.08273.54406.89337.85
Profit/Loss After Tax And Before ExtraOrdinary Items698.53772.46781.041211.66996.96
      
Profit/Loss From Continuing Operations698.53772.46781.041211.66996.96
      
Profit/Loss For The Period698.53772.46781.041211.66996.96
Consolidated Profit/Loss After MI And Associates698.53772.46781.041211.66996.96
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)42.4046.9047.4473.8163.07
Diluted EPS (Rs.)42.4046.9047.4373.8162.99
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]5616.50
Other Operating Revenues0.00
Total Operating Revenues5616.50
Other Income213.61
Total Revenue5830.11
EXPENSES 
Cost Of Materials Consumed1972.48
Purchase Of Stock-In Trade14.49
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade103.41
Employee Benefit Expenses1401.56
Finance Costs42.00
Depreciation And Amortisation Expenses377.87
Other Expenses855.64
Total Expenses4767.45
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1062.66
Exceptional Items0.00
Profit/Loss Before Tax1062.66
Tax Expenses-Continued Operations 
Current Tax364.13
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses364.13
Profit/Loss After Tax And Before ExtraOrdinary Items698.53
Profit/Loss From Continuing Operations698.53
Profit/Loss For The Period698.53
Consolidated Profit/Loss After MI And Associates698.53
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)42.40
Diluted EPS (Rs.)42.40